Accordingly, we show that SKF96365 treatment significantly reduced the control TNBC xenograft tumor growth (Figure 10B); we were unable to test the SOCE inhibitor against EHD2-KO TNBC xenografts as these did not grow sufficiently to test the inhibitor impact. Here, EHD2 is linked to neoplasm.